STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy (STRONGER): study protocol for a randomised, open label clinical trial in patients with persistent neurological symptoms after COVID-19 infection

Introduction Increasing awareness of the high frequency, wide spectrum and disabling nature of symptoms that can persist following COVID-19 infection has prompted the investigation of management strategies. Our study aims to determine the effectiveness of atorvastatin on cognitive function, physical...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Sharon L Naismith, Mark Woodward, Ruth Peters, Xia Wang, Craig S Anderson, Sophia Zoungas, Cheryl Carcel, Paula Muñoz-Venturelli, Karin Leder, Ian H Harding, Meng Law, Julian Elliott, Owen Hutchings, Carlos Delfino, Xiaolei Lin, Nirupama Wijesuriya, Ximena Stecher
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMJ Publishing Group 2025-04-01
Edice:	BMJ Open
On-line přístup:	https://bmjopen.bmj.com/content/15/4/e089382.full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!